Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Revascularization reduces mortality in patients with high risk coronary artery disease based on multi-slice CT

Original title: All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (Coronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry) Reference: James K Min et al. European Heart Journal (2012) 33, 3088–3097 doi:10.1093/eurheartj/ehs315.

Several large studies have shown revascularization reduces mortality in stable patients with high risk CAD based on conventional angiography. The goal of this study was to determine the impact in mortality rate of revascularization vs. medical therapy of patients with coronary disease based on CT. 

This observational study included 15223 patients without known coronary condition undergoing multi-slice coronary CT (≥ 64 detectors), divided in high risk (two-vessel CAD with proximal left anterior descending artery involvement, three-vessel CAD, and left main CAD) and low risk CAD. To identify revascularization or medical therapy predictors, they created a score developed by logistic regression. The primary end point was all-cause mortality. 

Revascularization rate was different depending on severity, from 3.8% for non-high-risk CAD to 51.2% high-risk CAD (p<0.01). 82.8% of revascularized patients were treated with angioplasty. Follow up median was 2.1 years (interquartile range 1.4-3.3 years).

After adjusting confounding factors, a reduction in all-cause mortality rates was observed in revascularized patients with high risk CAD, compared to those that received medical therapy (2.28% vs. 5.34% respectively p=0.0075). In low risk CAD patients no differences were observed (2.06% vs. 0.97% p=0.138).

Conclusion 

In patients with no previous history of CAD classified as high risk CAD patients based on multi-slice CT, revascularization reduced all-cause mortality rate.

Editorial Comment:

As an observation study, all outcomes produce more hypotheses that require further randomized studies. On the other hand, CTs are competing with functional studies as screening techniques and this study provides us with the tools to decide when to proceed with coronary angiography and revascularization.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...